Matthias Schmitt-Haendle

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study

Judith Haschka, Matthias Englbrecht, Axel J. Hueber et al. · Annals of the Rheumatic Diseases · 2015 · 189 citations

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment

Jürgen Rech, Axel J. Hueber, Stephanie Finzel et al. · Annals of the Rheumatic Diseases · 2015 · 89 citations · Full text

Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs

Camille P. Figueiredo, Holger Bang, Jayme Fogagnolo Cobra et al. · Annals of the Rheumatic Diseases · 2016 · 55 citations

Dual Selection Pressure by Drugs and HLA Class I-Restricted Immune Responses on Human Immunodeficiency Virus Type 1 Protease

Sandra M. Mueller, Birgit Schaetz, Kathrin Eismann et al. · Journal of Virology · 2007 · 31 citations · Full text

Immunodeficiencies, Immunology, Immunodominance +18

Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial

Koray Taşçılar, Melanie Hagen, Arnd Kleyer et al. · The Lancet Rheumatology · 2021 · 27 citations

Rheumatoid Disorder, Rheumatology, Rheumatic Diseases +8